Mavacoxib
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Trade names | Trocoxil |
AHFS/Drugs.com | International Drug Names |
ATCvet code | QM01AH92 (WHO) |
Identifiers | |
CAS Number | 170569-88-7 |
PubChem (CID) | 9843089 |
ChemSpider | 8018804 |
UNII | YFT7X7SR77 |
ChEBI | CHEBI:76207 |
Chemical and physical data | |
Formula | C16H11F4N3O2S |
Molar mass | 385 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease.[1] It acts as a COX-2 inhibitor.[2]
References[edit]
- ^ European Public Assessment Report (EPAR): Trocoxil, European Medicines Agency
- ^ Cox, S. R.; Lesman, S. P.; Boucher, J. F.; Krautmann, M. J.; Hummel, B. D.; Savides, M.; Marsh, S.; Fielder, A.; Stegemann, M. R. (2010). "The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs". Journal of Veterinary Pharmacology and Therapeutics. 33 (5): 461–70. doi:10.1111/j.1365-2885.2010.01165.x. PMID 20840390.
This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |